Evidence map›Paper›PMID 24853916›Full record

ArticleElectrophoresis2014

Variation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisition.

Anna M Zawadzka, Birgit Schilling, Jason M Held, Alexandria K Sahu, Michael P Cusack, Penelope M Drake, Susan J Fisher, Bradford W Gibson

Open access · greenAbstract read
In one paragraph

Article in Electrophoresis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2016
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Anna M ZawadzkaBuck Institute for Research on Aging, Novato, CA, USA.
Birgit Schilling
Jason M Held
Alexandria K Sahu
Michael P Cusack
Penelope M Drake
Susan J Fisher
Bradford W Gibson
Buck Institute for Research on Aging · USUniversity of California System · USUniversity of California, San Francisco · USWashington University in St. Louis · US

Funding

Targeted and global proteomic strategies for early breast cancer detectionU24CA126477 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISHER, SUSAN J. · 2006 to 2011
$8.7M
TripleTOF 5600 High Resolution Mass SpectrometerS10OD016281 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI GIBSON, BRADFORD WAYNE · 2013 to 2013
$597k
AB SCIEX QTRAP 5500 LC MS/MS systemS10RR027953 · NCRR · BUCK INSTITUTE FOR RESEARCH ON AGING · PI GIBSON, BRADFORD WAYNE · 2010 to 2010
$500k
QSTAR Elite Quadrupole-o-TOF LC/MS/MS SystemS10RR024615 · NCRR · BUCK INSTITUTE FOR RESEARCH ON AGING · PI GIBSON, BRADFORD WAYNE · 2007 to 2007
$466k
NCI NIH HHS U24 CA126477NCRR NIH HHS S10 RR024615NCRR NIH HHS S10 RR027953NIH HHS 1S10 OD016281NIH HHS S10 OD016281
6 · The paper itself

Abstract

Human plasma contains proteins that reflect overall health and represents a rich source of proteins for identifying and understanding disease pathophysiology. However, few studies have investigated changes in plasma phosphoproteins. In addition, little is known about the normal variations in these phosphoproteins, especially with respect to specific sites of modification. To address these questions, we evaluated variability in plasma protein phosphorylation in healthy individuals using multiple reaction monitoring (MRM) and SWATH-MS2 data-independent acquisition. First, we developed a discovery workflow for phosphopeptide enrichment from plasma and identified targets for MRM assays. Next, we analyzed plasma from healthy donors using an analytical workflow consisting of MRM and SWATH-MS2 that targeted phosphopeptides from 58 and 68 phosphoproteins, respectively. These two methods produced similar results showing low variability in 13 phosphosites from 10 phosphoproteins (CVinter < 30%) and high interpersonal variation of 16 phosphosites from 14 phosphoproteins (CVinter > 30%). Moreover, these phosphopeptides originate from phosphoproteins involved in cellular processes governing homeostasis, immune response, cell-extracellular matrix interactions, lipid and sugar metabolism, and cell signaling. This limited assessment of technical and biological variability in phosphopeptides generated from plasma phosphoproteins among healthy volunteers constitutes a reference for future studies that target protein phosphorylation as biomarkers.

Indexed as

AdolescentAdultAmino Acid SequenceChromatography, LiquidFemaleHumansMaleMiddle AgedMolecular Sequence DataPhosphopeptidesPhosphorylationProteomicsTandem Mass SpectrometryWorkflowYoung AdultPhosphopeptidesBiomarkersCancerMSPhosphorylation

Identifiers

PMID24853916
PMCPMC4565165
OpenAlexW1490809750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.